ERα and ERβ expression in correlation with Ki-67, Bcl-2 and Bak in primary tumors and lymph node metastases of breast cancer: The effect of pre-operative chemotherapy

Kanczuga-Koda,Luiza; Koda,Mariusz; Tomaszewski,jakub; Jarzabek,Katarzyna; Lotowska,Joanna; Baltaziak,marek; Sulkowska,Urszula; Sobaniec-Lotowska,Maria; Sulkowski,Stanisław

doi:10.3892/ol.2010.178

ERα and ERβ expression in correlation with Ki-67, Bcl-2 and Bak in primary tumors and lymph node metastases of breast cancer: The effect of pre-operative chemotherapy

Authors:
- Luiza Kanczuga-Koda
- Mariusz Koda
- jakub Tomaszewski
- Katarzyna Jarzabek
- Joanna Lotowska
- marek Baltaziak
- Urszula Sulkowska
- Maria Sobaniec-Lotowska
- Stanisław Sulkowski
View Affiliations

Affiliations: Department of Pathology, Maria Sklodowska-Curie Memorial Bialystok Oncology Center, 15-027 Bialystok, Poland, Department of Gynaecological Endocrinology, Medical University of Bialystok, 15-269 Bialystok, Poland, Department of General Pathomorphology, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland
Published online on: September 23, 2010 https://doi.org/10.3892/ol.2010.178
Pages: 1067-1072

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study aimed to assess the pre-operative chemotherapy impact on the relationship between estrogen receptor (ER) expression and markers of proliferation and apoptosis in primary and metastatic breast cancer. Immunohistochemical examinations were conducted on surgically removed ductal invasive breast cancers and their lymph node metastases in 135 patients. A total of 64 patients from this group underwent pre-operative chemotherapy and in 71 cases the surgery was performed without primary chemotherapy. A negative correlation between ERα and Ki-67 was found in primary tumors and lymph node metastases. A positive correlation was observed between ERα and Bcl-2. A positive correlation was also noted between ERβ and Bak, suggesting that the two ERs were involved in the regulation of proteins responsible for the control of the apoptotic process. Assessment of the expression of the proteins conducted separately in primary tumors and lymph node metastases did not reveal a significant effect of pre-operative chemotherapy on the correlations of ERs with Ki-67, Bcl-2 and Bak. However, the analysis of the correlations between the receptor expression in primary tumors and Ki-67, Bcl-2 and Bak in lymph node metastases showed a statistically significant impact of pre-operative chemotherapy on the correlations of ERα and Bcl-2 with ERβ and Bak, confirming involvement of the two ERs in the regulation of apoptosis during breast carcinogenesis.

View Figures

View References

1	Stewart AJ, Westley BR and May FE: Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen. Br J Cancer. 66:640–648. 1992. View Article : Google Scholar : PubMed/NCBI
2	Santen RJ, Fan P, Zhang Z, Bao Y, Song RX and Yue W: Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells. Steroids. 74:586–594. 2009. View Article : Google Scholar : PubMed/NCBI
3	Yamashita H: Current research topics in endocrine therapy for breast cancer. Int J Clin Oncol. 13:380–383. 2008. View Article : Google Scholar : PubMed/NCBI
4	Hopp TA, Weiss HL, Parra IS, Cui Y, Osborne CK and Fuqua SA: Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer. Clin Cancer Res. 10:7490–7499. 2004. View Article : Google Scholar : PubMed/NCBI
5	Gonzalez-Angulo AM, Morales-Vasquez F and Hortobagyi GN: Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol. 608:1–22. 2007. View Article : Google Scholar : PubMed/NCBI
6	Bos R, van Diest PJ, van der Groep P, Shvarts A, Greijer AE and van der Wall E: Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related. Breast Cancer Res. 6:R450–R459. 2004. View Article : Google Scholar : PubMed/NCBI
7	Nolan MK, Jankowska L, Prisco M, Xu S, Guvakova MA and Surmacz E: Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells. Int J Cancer. 72:828–834. 1997. View Article : Google Scholar : PubMed/NCBI
8	Surmacz E: Function of the IGF-I receptor in breast cancer. J Mammary Gland Biol Neoplasia. 5:95–105. 2000. View Article : Google Scholar : PubMed/NCBI
9	Koda M, Sulkowski S, Kanczuga-Koda L, Surmacz E and Sulkowska M: Expression of ERα, ERβ and Ki-67 in primary tumors and lymph node metastases in breast cancer. Oncol Rep. 11:753–759. 2004.
10	Koda M, Sulkowska M, Kanczuga-Koda L and Sulkowski S: Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases. J Clin Pathol. 58:645–649. 2005. View Article : Google Scholar : PubMed/NCBI
11	Koda M, Kanczuga-Koda L, Reszec J, Sulkowska M, Famulski W, Baltaziak M, Kisielewski W and Sulkowski S: Expression of the apoptotic markers in normal breast epithelium, benign mammary dysplasia and in breast cancer. Folia Morphol. 63:337–341. 2004.PubMed/NCBI
12	Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J, Russo A, Sulkowski S and Surmacz E: Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res. 12:1447–1453. 2006. View Article : Google Scholar : PubMed/NCBI
13	Redondo M, Garcia J, Rodrigo I, Villar E, González C and Morell M: Expression of bax and p53 proteins in the tumorigenesis and progression of breast carcinomas. Tumor Biol. 24:23–31. 2003. View Article : Google Scholar : PubMed/NCBI
14	Arun B, Kilic G, Yen C, Foster B, Yardley D, Gaynor R and Ashfaq R: Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes. Cancer. 98:2554–2559. 2003. View Article : Google Scholar : PubMed/NCBI
15	Koda M, Lenczewski A, Sulkowska M, Kanczuga-Koda L, Wincewicz A, Tomaszewski J and Sulkowski S: The effect of chemotherapy on status of estrogen receptors in primary tumors and lymph node metastases of human ductal breast cancer. Oncol Rep. 17:385–391. 2007.PubMed/NCBI
16	Koda M, Sulkowska M, Kanczuga-Koda L, Tomaszewski J, Kucharczuk W, Lesniewicz T, Cymek S and Sulkowski S: The effect of chemotherapy on Ki-67, Bcl-2 and Bak expression in primary tumors and lymph node metastases of breast cancer. Oncol Rep. 18:113–119. 2007.PubMed/NCBI
17	Koda M, Sulkowski S, Garofalo C, Kańczuga-Koda L, Sulkowska M and Surmacz E: Expression of the insulin-like growth factor-I receptor in primary breast cancer and lymph node metastases: correlations with estrogen receptors α and β. Horm Metab Res. 35:794–801. 2003.PubMed/NCBI
18	Koda M, Przystupa W, Jarzabek K, Wincewicz A, Kanczuga-Koda L, Tomaszewski J, Sulkowska M, Wolczynski S and Sulkowski S: Expression of insulin-like growth factor-I receptor, estrogen receptor α, Bcl-2 and Bax proteins in human breast cancer. Oncol Rep. 14:93–98. 2005.
19	Wu JM, Fackler MJ, Halushka MK, Molavi DW, Taylor ME, Teo WW, Griffin C, Fetting J, Davidson NE, De Marzo AM, Hicks JL, Chitale D, Ladanyi M, Sukumar S and Argani P: Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases. Clin Cancer Res. 14:1938–1946. 2008. View Article : Google Scholar
20	Rochaix P, Krajewski S, Reed JC, Bonnet F, Voigt JJ and Brousset P: In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis. J Pathol. 187:410–415. 1999. View Article : Google Scholar : PubMed/NCBI
21	Ferrieres G, Cuny M, Simony-Lafontaine J, Jacquemier J, Rouleau C, Guilleux F, Grenier J, Rouanet P, Pujol H, Jeanteur P and Escot C: Variation of bcl-2 expression in breast ducts and lobules in relation to plasma progesterone levels: overexpression and absence of variation in fibroadenomas. J Pathol. 183:204–211. 1997. View Article : Google Scholar : PubMed/NCBI
22	Leung LK and Wang TT: Paradoxical regulation of Bcl-2 family proteins by 17β-oestradiol in human breast cancer cells MCF-7. Br J Cancer. 81:387–392. 1999.PubMed/NCBI
23	Berardo MD, Elledge RM, de Moor C, Clark GM, Osborne CK and Allred DC: Bcl-2 and apoptosis in lymph node positive breast carcinoma. Cancer. 82:1296–1302. 1998. View Article : Google Scholar : PubMed/NCBI
24	Sierra A, Castellsague X, Coll T, Manas S, Escobedo A, Moreno A and Fabra A: Expression of death-related genes and their relationship to loss of apoptosis in T1 ductal breast carcinomas. Int J Cancer. 79:103–110. 1998. View Article : Google Scholar : PubMed/NCBI
25	Gueth U, Huang DJ, Schoetzau A, Holzgreve W and Wight E: Systemic therapy of metastatic breast cancer: the truth beyond the clinical trials. Oncology. 76:247–253. 2009. View Article : Google Scholar : PubMed/NCBI